Aerosols Transmit Prions to Immunocompetent and Immunodeficient Mice by Haybaeck, Johannes et al.
Aerosols Transmit Prions to Immunocompetent and
Immunodeficient Mice
Johannes Haybaeck
1.¤a, Mathias Heikenwalder
1.¤b, Britta Klevenz
2., Petra Schwarz
1, Ilan Margalith
1,
Claire Bridel
1, Kirsten Mertz
1,3, Elizabeta Zirdum
2, Benjamin Petsch
2, Thomas J. Fuchs
4, Lothar Stitz
2*,
Adriano Aguzzi
1*
1Department of Pathology, Institute of Neuropathology, University Hospital Zurich, Zurich, Switzerland, 2Institute of Immunology, Friedrich-Loeffler-Institut, Tu ¨bingen,
Germany, 3Department of Pathology, Clinical Pathology, University Hospital Zurich, Zurich, Switzerland, 4Department of Computer Science, Machine Learning
Laboratory, ETH Zurich, Zurich, Switzerland
Abstract
Prions, the agents causing transmissible spongiform encephalopathies, colonize the brain of hosts after oral, parenteral,
intralingual, or even transdermal uptake. However, prions are not generally considered to be airborne. Here we report that
inbred and crossbred wild-type mice, as well as tga20 transgenic mice overexpressing PrP
C, efficiently develop scrapie upon
exposure to aerosolized prions. NSE-PrP transgenic mice, which express PrP
C selectively in neurons, were also susceptible to
airborne prions. Aerogenic infection occurred also in mice lacking B- and T-lymphocytes, NK-cells, follicular dendritic cells or
complement components. Brains of diseased mice contained PrP
Sc and transmitted scrapie when inoculated into further
mice. We conclude that aerogenic exposure to prions is very efficacious and can lead to direct invasion of neural pathways
without an obligatory replicative phase in lymphoid organs. This previously unappreciated risk for airborne prion
transmission may warrant re-thinking on prion biosafety guidelines in research and diagnostic laboratories.
Citation: Haybaeck J, Heikenwalder M, Klevenz B, Schwarz P, Margalith I, et al. (2011) Aerosols Transmit Prions to Immunocompetent and Immunodeficient
Mice. PLoS Pathog 7(1): e1001257. doi:10.1371/journal.ppat.1001257
Editor: David Westaway, University of Alberta, Canada
Received March 22, 2010; Accepted December 13, 2010; Published January 13, 2011
Copyright:  2011 Haybaeck et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported in part by EU grants ANTEPRION and PRIORITY (LS), and the TSE-Forschungsprogramm des Landes Baden-Wuerttemberg,
Germany (LS). This work was also supported by grants from the UK Department of Environment, Food and Rural Affairs (AA), the EU grants LUPAS and PRIORITY
(AA), the Novartis Research Foundation (AA), and an Advanced Grant of the European Research Council to AA. MH was supported by the Foundation for Research
at the Medical Faculty, the Prof. Dr. Max-Cloetta foundation and the Bonizzi-Theler Foundation. The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: adriano.aguzzi@usz.ch (AA); lothar.stitz@fli.bund.de (LS)
¤a Current address: Institute of Pathology, Medical University Graz, Graz, Austria
¤b Current address: Institute of Virology, Technical University Mu ¨nchen/Helmholtz Zentrum Mu ¨nchen, Munich, Germany
. These authors contributed equally to this work.
Introduction
Transmissible spongiform encephalopathies (TSEs) are fatal
neurodegenerative disorders that affect humans and various
mammals including cattle, sheep, deer, and elk. TSEs are
characterized by the conversion of the cellular prion protein
(PrP
C) into a misfolded isoform termed PrP
Sc [1]. PrP
Sc
aggregation is associated with gliosis, spongiosis, and neurodegen-
eration [2] which invariably leads to death. Prion diseases have
been long known to be transmissible [3], and prion transmission
can occur after oral, corneal, intraperitoneal (i.p.), intravenous
(i.v.), intranasal (i.n.), intramuscular (i.m.), intralingual, transder-
mal and intracerebral (i.c.) application, the most efficient being i.c.
inoculation [4,5,6,7,8,9,10,11,12]. Several biological fluids and
excreta (e.g. saliva, milk, urine, blood, placenta, feces) contain
significant levels of prion infectivity [13,14,15,16,17], and
horizontal transmission is believed to be critical for the natural
spread of TSEs [18,19,20,21,22,23]. Free-ranging animals may
absorb infectious prion particles through feeding or drinking
[24,25], and tongue wounds may represent entry sites for prions
[26].
PrP
Sc has also been found in the olfactory epithelium of
sCJD patients [27,28]. Prion colonization of the nasal epithelium
occurs in various species and with various prion strains
[11,12,29,30,31,32,33,34,35,36,37]. In the HY-TME prion mod-
el, intranasal application is 10–100 times more efficient than oral
uptake [29] and, as in many other experimental paradigms
[38,39,40,41,42,43,44], the lymphoreticular system (LRS) is the
earliest site of PrP
Sc deposition. A publication demonstrated
transmission of chronic wasting disease (CWD) in cervidized mice
via aerosols and upon intranasal inoculation [45], yet two studies
reported diametrically differing results on the role of the olfactory
epithelium or the LRS in prion pathogenesis upon intranasal prion
inoculation [11,12], perhaps because of the different prion strains
and animal models used. These controversies indicate that the
mechanisms of intranasal and aerosolic prion infection are not
fully understood. Furthermore, intranasal administration is
physically very different from aerial prion transmission, as the
airway penetration of prion-laden droplets may be radically
different in these two modes of administration.
Here we tested the cellular and molecular characteristics of
prion propagation after aerosol exposure and after intranasal
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independent of the immune system, even though we used a
strongly lymphotropic prion strain. Aerosols proved to be efficient
vectors of prion transmission in mice, with transmissibility being
mostly determined by the exposure period, the expression level of
PrP
C, and the prion titer.
Results
Prion transmission via aerosols
Prion aerosols were produced by a nebulizing device with brain
homogenates at concentrations of 0.1–20% (henceforth always
indicating weight/volume percentages) derived from terminally
scrapie-sick or healthy mice, and immitted into an inhalation
chamber. As per the manufacturer’s specifications, aerosolized
particles had a maximal diameter of ,10 mm, and approximately
60% were ,2.5 mm [46].
Groups of mice overexpressing PrP
C (tga20; n=4–7) were
exposed to prion aerosols derived from infectious or healthy brain
homogenates (henceforth IBH and HBH) at various concentrations
(0.1, 2.5, 5, 10 and 20%) for 10 min (Fig. 1A, Table 1). All tga20
mice exposed to aerosols derived from IBH (concentration: $2.5%)
succumbed to scrapie with an attack rate of 100%. The incubation
time negatively correlated with the IBH concentration (2.5%: n=4,
165654 dpi; 5%: n=4, 13167 dpi; 10%: n=5, 161627 dpi;
20%: n=6, 13368 dpi; p=0.062, standard linear regression on
standard ANOVA; Fig. 1A and F, Table 1, Table S1A).
tga20 mice exposed to aerosolized 0.1% IBH did not develop
clinical scrapie within the observational period (n=4; experiment
terminated after 300 dpi), yet displayed brain PrP
Sc indicative of
subclinical prion infection (Fig. 1A and 2A). In contrast, control
tga20 mice (n=4) exposed to aerosolized HBH did not develop
any recognizable disease even when kept for $300 dpi, and their
brains did not exhibit any PrP
Sc in histoblots and Western blots
(data not shown).
In the above experiments, and in all experiments described in
the remainder of this study, all PrP-expressing (tga20 and WT)
mice diagnosed as terminally scrapie-sick were tested by Western
blot analysis and by histology: all were invariably found to contain
PrP
Sc in their brains (Fig. 2) and to display all typical
histopathological features of scrapie including spongiosis, PrP
deposition and astrogliosis (Fig. 1H).
Correlation of exposure time to prion aerosols and
incubation period
We then sought to determine the minimal exposure time that
would allow prion transmission via aerosols (Fig. 1B, Table 1).
tga20 mice were exposed to aerosolized IBH (20%) for various
durations (1, 5 or 10 min) in two independent experiments.
Surprisingly, an exposure time of only 1 min was found to be
sufficient to induce a 100% scrapie attack rate. Longer exposures
to prion-containing aerosols strongly correlated with shortened
incubation periods (Fig. 1B and G, Table 1, Table S1A and B).
In order to test the universality of the above results, we
examined whether aerosols can transmit prions to various mouse
strains (CD1, C57BL/6; 129SvxC57BL/6) expressing wild-type
(wt) levels of PrP
C. CD1 mice were exposed to aerosolized 20%
IBH in two independent experiments (Fig. 1C, Table 1). After 5 or
10-min exposures, all CD1 mice succumbed to scrapie whereas
shorter exposure (1 min) led to attack rates of 0–50% [1 min
exposure (first experiment): scrapie in 0/3 mice; 1 min exposure
(second experiment): 2/4 mice died of scrapie at 20260 dpi;
5 min (first experiment): n=4, attack rate 100%, 202612 dpi;
5 min (second experiment): n=3, attack rate 100%, 20260 dpi;
10 min (first experiment): n=4, attack rate 100%, 20260 dpi;
10 min (second experiment): n=4, attack rate 100%,
206616 dpi]. In CD1 mice exposed to prion-containing aerosols
for longer intervals, we detected a trend towards shortened
incubation times which did not attain statistical significance (Table
S1A and S1B).
We also investigated whether C57BL/6 or 129SvxC57BL/6
mice would succumb to scrapie upon exposure to prion aerosols
(Fig. 1D and E, Table 1). A 10 min exposure time with a 20% IBH
led to an attack rate of 100% (C57BL/6: 10 min: n=4;
185611 dpi; 129SvxC57BL/6: n=5; 10 min: 182615 dpi).
Control Prnp
o/o mice (129SvxC57BL/6 background; n=3) were
resistant to aerosolized prions (20%, 10 min) as expected (Fig. 1E
and H, Table 1).
Incubation time and attack rate depends on PrP
C
expression levels
When tga20 mice were challenged for 10 min, variations in the
concentration of aerosolized IBH had a barely significant influence
on survival times (p=0.062; Fig. 1F), whereas variations in the
duration of exposure of tga20 mice affected their life expectancy
significantly (p,0.001; Fig. 1G). Furthermore tga20 mice, which
express6–9foldmorePrP
Cinthecentralnervoussystem(CNS)than
wt mice [46,47,48], succumbed significantly earlier to scrapie upon
prion aerosol exposure for 10 min (20%) (tga20 mice: 13464 dpi;
CD1 mice: 202612 dpi, p,0.0001; C57BL/6 mice: 185611 dpi,
p=0.003; 129SvxC57BL/6 mice: 182615 dpi, p=0.003; Fig. 1B–
E,Fig. S1, TableS1A and S1C). Incubation time wasprolonged and
transmission was less efficient in CD1 mice than in tga20 mice after
a 1 min exposure to prion aerosols (20%). The variability of
incubation times between CD1 mice was low (1
st vs. 2
nd experiment
with 5-min exposure: p=0.62, 1
st vs. 2
nd experiment with 10-min
exposure: p=0.27; Fig. 1C, Table 1). This suggests that 1 min
exposure of CD1 mice to prion aerosols (20%) suffices for uptake of
#1LD50 infectious units. This finding underscores the importance
ofPrP
C expression levelsnot only for theincubation timebut also for
susceptibility to infection and neuroinvasion upon exposure to
aerosols. Histoblot analyses confirmed deposition of PrP
Sc in brains
of tga20 mice exposed to prion aerosols derived from 10% or 20%
IBH, whereas no PrP
Sc was found in brains of Prnp
o/o mice exposed
to prion aerosols (Fig. 2D).
We then performed a semiquantitative analysis of the
histopathological lesions in the CNS. The following brain regions
were evaluated according to a standardized severity score
(astrogliosis, spongiform change and PrP
Sc deposition; [49]):
hippocampus, cerebellum, olfactory bulb, frontal white matter,
and temporal white matter. Scores were compared to those of
Author Summary
Prions, which are the cause of fatal neurodegenerative
disorders termed transmissible spongiform encephalopa-
thies (TSEs), can be experimentally or naturally transmitted
via prion-contaminated food, blood, milk, saliva, feces and
urine. Here we demonstrate that prions can be transmitted
through aerosols in mice. This also occurs in the absence
of immune cells as demonstrated by experiments with
mice lacking B-, T-, follicular dendritic cells (FDCs),
lymphotoxin signaling or with complement-deficient mice.
Therefore, a functionally intact immune system is not
strictly needed for aerogenic prion infection. These results
suggest that current biosafety guidelines applied in
diagnostic and scientific laboratories ought to include
prion aerosols as a potential vector for prion infection.
Prion Transmission by Aerosols
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terminally scrapie-sick mice (tga20, CD1, C57BL/6 and
129SvxC57BL/6) infected i.c. or through aerosols were similar
irrespectively of genetic background or PrP
C expression levels
(Fig. 2E and F), with CD1 and 129SvxC57BL/6 hippocampi and
cerebella displaying only mild histological and immunohistochem-
ical features of scrapie regardless of the route of inoculation.
We attempted to trace PrP
Sc in the nasopharynx, the nasal
cavity or various brain regions early after prion aerosol infection
(1–6 hrs post exposure) and at various time points after intranasal
inoculations (6, 12, 24, 72, 144 hrs, 140 dpi, and terminally) with
various methods including Western blot, histoblot and protein
misfolding analyses. However, none of these analyses detected
PrP
Sc shortly after exposure to prion aerosols (6–72 hrs post prion
aerosol exposure) whereas at 140 dpi or terminal stage PrP
Sc was
detected by all of these methods (Fig. S2; data not shown).
PrP
C expression on neurons allows prion neuroinvasion
upon infection with prion aerosols
We then investigated whether PrP
C expression in neurons
would suffice to induce scrapie after exposure to prions through
aerosols. NSE-PrP transgenic mice selectively express PrP
C in
neurons and if bred on a Prnp
o/o background (Prnp
o/o/NSE-PrP)
display CNS-restricted PrP expression levels similar to wt mice
[50].
Prnp
o/o/NSE-PrP (henceforth referred to as NSE-PrP) mice were
exposed to prion aerosols (20% homogenate; 10 min). All NSE-PrP
mice succumbed to terminal scrapie (21668 dpi; n=4; Fig. 1E,
2G, Table 1), although incubation times were significantly longer
than those of wt 129SvxC57BL/6 mice (180615 dpi; n=5;
p=0.004). Histology and immunohistochemistry confirmed scra-
pie in NSE-PrP brains (Fig. 2H and I). Histopathological lesion
severity score analysis (see above) revealed a lesion profile roughly
Table 1. Survival times of different mouse strains exposed to prion aerosols for various periods.
Genotype
inoculum
concentr. exposure (min) n
attack
rate Incubation time (dpi)
tga20 0.1% 10 4 0/4 .300 .300 .300 .300
tga20 2.5% 10 4 4/4 120 121 208 219
tga20 5% 10 4 4/4 122 129 133 138
tga20 10% 10 5 5/5 124 133 161 167 191
tga20 20% 10 6 6/6 120 120 133 133 133 140
CD1 20% 1 3 0/3 .300 .300 .300
CD1* 20% 1 4 2/4 202 202 .300 .300
tga20 20% 1 3 3/3 134 174 189
tga20* 20% 1 3 3/3 203 204 205
CD1 20% 5 4 4/4 182 202 202 209
CD1* 20% 5 3 3/3 202 202 202
tga20 20% 5 4 4/4 136 170 170 174
tga20* 20% 5 4 4/4 127 134 136 136
CD1 20% 10 4 4/4 202 202 202 202
CD1* 20% 10 4 4/4 202 202 211 235
tga20 20% 10 4 4/4 134 138 142 142
tga20* 20% 10 4 4/4 132 133 134 134
C57BL/6 20% 10 4 4/4 164 182 188 188
129SvxC57BL/6 20% 10 5 5/5 155 180 182 184 197
Prnp
o/o 20% 10 3 0/3 .300 .300 .300
newborn tga20 20% 10 3 3/3 157 189 189
newborn CD1 20% 10 3 3/3 211 211 211
Upper panel: survival times of tga20 mice after 10-min exposure to aerosols generated from various concentrations of IBH. Lower panel: survival times of various mouse
strains after exposure for 1, 5, or 10 min to infectious aerosols. Selected inoculations were repeated sequentially (asterisks) in order to estimate the reproducibility of
these results.
doi:10.1371/journal.ppat.1001257.t001
Figure 1. Prion transmission through aerosols. (A) tga20 mice were exposed to aerosols generated from 0.1%, 2.5%, 5%, 10% or 20% prion-
infected mouse brain homogenates (IBH) for 10 min. (B) Groups of tga20 and (C) CD1 mice were exposed for 1, 5 or 10 min to aerosols generated
from a 20% IBH. Experiments were performed twice (different colors). (D) C57BL/6, (E) 129SvxC57BL/6, and Prnp
o/o mice were exposed for 10 min to
aerosols generated from 20% IBH. Kaplan-Meier curves describe the percentage of survival after particular time points post exposure to prion
aerosols (y-axis represents percentage of living mice; x-axis demonstrates survival time in days post inoculation). Different colors and symbols
describe the various experimental groups. (F) Jittered scatter plot of survival time against concentration of prion aerosols generated out of IBH with
added linear regression fit (p=0.0622). (G) Jittered scatter plot of survival time against exposure time for tga20 mice with added linear regression fit.
The negative correlation between survival time and exposure time is significant (p,0.001***). (H) Consecutive paraffin sections of the right
hippocampus of Prnp
o/o, tga20, CD1 and C57BL/6 mice stained with HE (for spongiosis, gliosis, neuronal cell loss), SAF84 (PrP
Sc deposits), GFAP
(astrogliosis) and Iba-1 (microglia). All animals had been exposed to aerosols generated from 20% IBH for 10 min. Scale bars: 100mm.
doi:10.1371/journal.ppat.1001257.g001
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severe lesions were observed in NSE-PrP cerebella whereas
olfactory bulbs were less affected.
Real time PCR analysis revealed 2–4 transgene copies per Prnp
allele in Prnp
o/o/NSE-PrP mice.
A detailed quantitative analysis of PrP
C expression levels at
various sites of the CNS was performed by comparing the signals
obtained by blotting various amounts of protein from NSE-PrP,w t
and tga20 tissues (Fig. S3). A value of 100 was arbitrarily assigned
to expression of PrP
C in wt tissues; olfactory epithelia of tga20 and
NSE-PrP mice expressed $350 and ,30, respectively (Fig. S3A).
In olfactory bulbs, tga20 and NSE-PrP mice expressed $150 and
30, respectively (Fig. S3B). In brain hemispheres tga20 and NSE-
PrP mice expressed .250 and .150, respectively (Fig. S3C).
Therefore, NSE-PrP mice expressed somewhat more PrP
C than wt
mice in brain hemispheres, but somewhat less in olfactory bulbs
and olfactory epithelia.
Aerosolic prion infection is independent of the immune
system
In many paradigms of extracerebral prion infection, efficient
neuroinvasion relies on the anatomical and physiological integrity
of several immune system components [40,42,43,44]. To deter-
mine whether this is true for aerosolic prion challenges, we
exposed immunodeficient mouse strains to prion aerosols. This
series of experiments included JH
2/2 mice, which selectively lack
B-cells, and cCRag2
2/2 mice which are devoid of mature B-, T-
and NK-cells (Fig. 3A). Upon exposure to prion aerosoIs (20%
IBH; exposure time 10 min) both JH
2/2 and cCRag2
2/2 mice
succumbed to scrapie with a 100% attack rate (JH
2/2:n = 6 ,
181621 dpi; cCRag2
2/2: n=11, 185641 dpi, p=0.65). The
incubation times were not significantly different to those of
C57BL/6 wt mice exposed to prion aerosols (JH
2/2 mice: p=0.9;
cCRag2
2/2 mice: p=0.7).
Histological and immunohistochemical analyses confirmed
scrapie in all clinically diagnosed mice. Lesion severity score
analyses (Fig. 3A and 3E) showed that JH
2/2 and cCRag2
2/2
mice had lower profile scores in cerebella and higher scores in
hippocampi and frontal white matter than C57BL/6 mice. Slightly
higher scores in temporal white mater areas and the thalamus
could be detected in JH
2/2 and cCRag2
/2/2 mice, whereas
cCRag2
2/2 mice showed lower scores in olfactory bulbs.
Consistently with several previous reports, cCRag2
2/2 mice
(n=4) did not succumb to scrapie after i.p. prion inoculation
(100ml RML6 0.1% 6 log LD50) even when exposed to a prion
titer that was twice higher than that used for intranasal
inoculations (data not shown).
Depending on the exposure time and the IBH concentration,
tga20 mice developed splenic PrP
Sc deposits. In contrast, none of
the scrapie-sick JH
2/2,L T bR
2/2 and cCRag2
2/2 mice displayed
any splenic PrP
Sc on Western blots and/or histoblots (Fig. S4A–D)
despite copious brain PrP
Sc.
Aerosol infection is independent of follicular dendritic
cells
Follicular dendritic cells (FDCs) are essential for prion replication
within secondary lymphoid organs and for neuroinvasion after i.p.
or oral prion challenge [42,44,51]. Lymphotoxin beta receptor-Ig
fusion protein (LTbR-Ig) treatment in C57BL/6 mice causes
dedifferentiation of mature FDCs, resulting in reduced peripheral
prion replication and neuroinvasion upon extraneural (e.g.
intraperitoneal or oral) prion inoculation [52,53]. We therefore
investigated whether FDCs are required for prion replication after
challenge with prion aerosols. C57BL/6 mice were treated with
LTbR-Ig or nonspecific pooled murine IgG (muIgG) before and
after prion challenge (27, 0, and +7 days) (Fig. 3B). The effects of
the LTbR-Ig treatment were monitored by Mfg-E8
+/FDC-M1
+
staining for networks of mature FDCs in lymphoid tissue. This
analysisrevealedacompletelossofMfg-E8
+/FDC-M1
+networksat
the day of prion exposure and at 14 dpi (data not shown).
LTbR-Ig treatment and dedifferentiation of FDCs did not alter
incubation times upon aerosol prion infection (LTbR-Ig: n=3,
attack rate 100%, 18460 dpi; muIgG: n=3, attack rate 100%,
18460 dpi) (Fig. 3B, Table 2). The diagnosis of terminal scrapie
was confirmed by histological and immunohistochemical analyses
in all clinically affected mice (Fig. 3B; data not shown).
Histopathological lesion severity scoring revealed that LTbR-Ig
treated C57BL/6 mice displayed a higher score in all regions
investigated than untreated C57BL/6 mice upon challenge with
prion aerosols (20% IBH; 10 min) (Fig. 2E and 3B). We found
slightly less severe scores in the olfactory bulbs of C57BL/6 mice
treated with muIgG than in untreated C57BL/6 mice upon
challenge with prion aerosols (Fig. 2E and 3B), and a slightly
higher score in the temporal white matter (exposure to 20%
aerosol for 10 min; Fig. 2E and 3B).
Prion aerosol infection of mice lacking LTbR or CD40L
LTbR signaling is essential for proper development of
secondary lymphoid organs and for maintenance of lymphoid
microarchitecture, and was recently shown to play an important
role in prion replication within ectopic lymphoid follicles and
granulomas [40,41,44]. To investigate the role of this pathway in
aerogenic prion infections, LTbR
2/2 mice were exposed to prion
aerosols (20% IBH; 10 min exposure time). All LTbR
2/2 mice
succumbed to scrapie (LTbR
2/2: n=4, 27260 dpi) and displayed
PrP deposits in their brains (Fig. 3C). Histological severity scoring
of aerosol-exposed mice revealed higher scores in LTbR
2/2
hippocampi and lower scores in cerebellum, olfactory bulb, frontal
and temporal white matter than in C57BL/6 controls (exposure:
20%; 10 min; Fig. 2E and 3C).
Figure 2. PrP
Sc deposition in brains of mice infected with prion aerosols and profiling of NSE-PrP mice. (A) Western blot analysis of brain
homogenates (10%) from terminal or subclinical tga20 mice exposed to aerosols from 20% or 0.1% IBH for 10 min. PK+ or 2: with or without
proteinase K digest; kDa: Kilo Dalton. (B–C): Western blot analyses of brain homogenates from tga20 (B) or CD1 (C) mice exposed to prion aerosols
from 20% IBH. (D) Histoblot analysis of brains from mice exposed to prion aerosols. Brains of tga20 mice challenged with aerosolized 10% (middle
panel) or 20% (right panel) IBH showed deposits of PrP
Sc in the cortex and mesencephalon. Because the brain of a Prnp
o/o mouse showed no signal
(left panel), we deduce that the signal in the middle and right panels represents local prion replication. (E) Histopathological lesion severity score
analysis of 5 brain regions depicted as radar plots [51] (astrogliosis, spongiform change and PrP
Sc deposition) derived from tga20, CD1, C57BL/6 and
129SvxC57BL/6 mice exposed to prion aerosols. Numbers correspond to the following brain regions: (1) hippocampus, (2) cerebellum, (3) olfactory
bulb, (4) frontal white matter, (5) temporal white matter. (F) Histopathological lesion severity score of 5 brain regions shown as radar blot
(astrogliosis, spongiform change and PrP
Sc deposition) of i.c. prion inoculated tga20, CD1, C57BL/6 and 129SvxC57BL/6 mice. (1) hippocampus, (2)
cerebellum, (3) olfactory bulb, (4) frontal white matter, (5) temporal white matter. (G) Survival curve and (H) lesion severity scores of NSE-PrP mice
exposed to a 20% aerosolized IBH for 10 min. (I) Histological and immunohistochemical characterization of scrapie-affected hippocampi of NSE-PrP
mice after exposure to aerosolized 20% IBH. Stain legend as in Fig. 1H. Scale bar: 100mm.
doi:10.1371/journal.ppat.1001257.g002
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infection. CD40
2/2 mice fail to develop germinal centers and
memory B-cell responses, yet CD40L
2/2 mice show unaltered
incubation times upon i.p. prion challenge [54]. Similarly to the
other immunocompromised mouse models investigated, CD40
2/2
mice developed terminal scrapie upon infection with prion
aerosols with an attack rate of 100% (n=3, 276650 dpi). Lesion
severity analyses of CD40
2/2 mice revealed a slightly higher score
in the cerebellum and the temporal white matter than in C57BL/6
mice (Fig. 2E and 3C). Therefore, LTbR and CD40 signaling are
dispensable for aerosolic prion infection.
Components of the complement system are dispensable
for aerosolic prion infection
Certaincomponentsofthecomplementsystem(e.g.C3;C1qa) play
an important role in early prion uptake, peripheral prion replication
and neuroinvasion after peripheral prion challenge [43,55,56]. We
have tested whether this is true also for exposure to prion aerosols.
Mice lacking both complement components C3 and C4 (C3C4
2/2)
were exposed for 10 min to 20% aerosolized IBH. All C3C4
2/2 mice
succumbed to scrapie (n=3, 382633 dpi; Fig. 4A). Histopathological
evaluation of all scrapie affected mice revealed astrogliosis,
spongiform changes and PrP-deposition in the CNS (Fig. 4A).
Table 2. Survival of mouse strains exposed to prion aerosols (upper panel) or intranasal administered prions (lower panel).
Genotype n
Attack
rate Survival (dpi)
Aerosol (20% IBH)
NSE-Prp 4 4/4 211 211 213 227
JH
2/2 6 6/6 140 184 184 188 190 198
cCRag2
2/2 11 11/11 121 134 141 165 169 187 224 224 224 224 227
C57BL/6 treated with LTbR-Ig 3 3/3 184 184 184
C57BL/6 treated with muIgG 3 3/3 184 184 184
LTbR
2/2 4 4/4 272 272 272 272
CD40
2/2 3 3/3 220 292 315
C3
2/2 C4
2/2 3 3/3 363 363 420
intranasal inoculation
Prnp
o/o 80 / 8.300 .300 .300 .300 .300 .300 .300 .300
C57BL/6 8 8/8 219 219 253 263 292 292 292 296
129SvxC57BL/6 5 5/5 187 213 213 235 235
Balbc 6 6/6 112 225 225 225 225 242
tga20 10 10/10 118 125 126 133 152 165 186 187 202 203
NSE-Prp 6 6/6 201 230 255 267 383 411
Rag1
2/2 9 9/9 198 198 198 200 203 203 204 210 214
cCRag2
2/2 16 16/16 224 224 224 229 241 242 242 242 244
244 256 258 264 265 265 319
C1qa
2/2 4 4/4 256 284 291 319
CD21
2/2 10 10/10 212 212 214 216 226 235 236 263 269 270
CXCR5
2/2 5 5/5 190 245 363 363 403
C57BL/6 treated with LTbR-Ig 8 8/8 219 222 407 413 475 638 717 717
C57BL/6 treated with muIgG 9 9/9 176 242 242 242 255 255 263 271 272
LTbR
2/2 6 6/6 223 252 263 314 346 348
TNFR1
2/2 3 3/3 213 213 214
LTa
2/2 6 6/6 233 234 238 255 262 283
C57BL/6 HBH 4 0/4 .300 .300 .300 .300
Balb/c HBH 4 0/4 .300 .300 .300 .300
Rag1
2/2 HBH 4 0/4 .300 .300 .300 .300
cCRag2
2/2 HBH 4 0/4 .300 .300 .300 .300
doi:10.1371/journal.ppat.1001257.t002
Figure 3. Prion transmission through aerosols in immunocompromised mice. Survival curves, lesion severity score analysis (radar plots),
and representative histopathological micrographs of mice with genetically or pharmacologically impaired components of the immune system (JH
2/2,
cCRag2
2/2A),129Sv mice treated with LTbR-Ig or with muIgG (B), and LTbR
2/2, and CD40
2/2 mice (C). All mice were exposed for 10 min to
aerosolized 20% IBH. Stain code: HE (spongiosis, gliosis, neuronal cell loss), SAF84 (PrP
Sc deposits), GFAP (astrogliosis) and Iba-1 (microglial activation)
as in Fig. 1H. Scale bars: 100mm.
doi:10.1371/journal.ppat.1001257.g003
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The data reported above argued in favor of direct neuroinva-
sion via PrP
C-expressing neurons upon aerosol administration.
However, a possible alternative mechanism of transmission may be
via the ocular route, namely via cornea, retina, and optic nerve
[57,58]. In order to test this possibility, newborn (,24 hours-old)
tga20 and CD1 mice, whose eyelids were still closed, were exposed
for 10 min to prion aerosols generated from a 20% IBH. All mice
succumbed to scrapie and showed PrP deposits in brains (tga20
mice: n=3, 173623 dpi; CD1 mice: n=3, 21160 dpi) (Fig. 4B).
Newborn tga20 mice succumbed to scrapie slightly later
(p=0.0043) than adult tga20 mice, whereas no differences were
observed between newborn and adult CD1 mice exposed for
10 min to prion aerosols generated from a 20% IBH (p=0.392).
The brains of all animals contained PK-resistant material, as
evaluated by Western blot analysis (data not shown). In addition,
untreated littermates or other sentinels which were reared or
housed together with aerosol-treated mice immediately following
exposure to aerosols showed neither signs of scrapie nor PrP
Sc in
brains, even after 482 dpi. This suggests that prion transmission
was the consequence of direct exposure of the CNS to prion
aerosols rather than the result of transmission via other routes like
ingestion from fur by grooming or exposure to prion-contaminated
feces or urine.
Lack of PrP
Sc in secondary lymphoid organs of
immunocompromised, scrapie-sick mice after infection
with prion aerosols
We further investigated additional mice for the occurrence of
PrP
Sc in secondary lymphoid organs upon exposure to prion
aerosols. PK-resistant material was searched for in spleens,
bronchial lymph nodes (bln) and mesenteric lymph nodes (mln)
at terminal stage of disease. C57BL/6, 129SvxC57BL/6, muIgG
treated C57BL/6 mice, newborn tga20 mice as well as newborn
CD1 mice contained PrP
Sc in the LRS, whereas LTbR
2/2 mice
and C57BL/6 mice treated with LTbR-Ig lacked PrP
Sc deposits in
spleens (Fig. S4A–F; Table 3).
The efficiency of intranasal prion inoculation depends on
the level of PrP
C expression
To dissect aerosol-mediated from non-aerosolic contributions to
prion exposure, we directly applied a prion suspension (RML 6.0,
0.1%, 40ml, corresponding to 4610
5 LD50 scrapie prions) to the
nasal mucosa of various mouse lines (Fig. S5). Since mice breathe
exclusively through their nostrils [59,60] we reasoned that this
procedure would simulate aerosolic transmission with sufficient
faithfulness although the mechanisms of prion uptake could still
differ between aerosolic and intranasal administration [11].
tga20 (n=10), 129SvxC57BL/6 (n=5), C57BL/6 (n=8) and
Prnp
o/o mice (n=8) were challenged intranasally with prions (Fig.
S5). To test the possibility that the inoculation procedure itself
might impact the life expectancy of mice, C57BL/6 mice (n=4)
were inoculated intranasally with healthy brain homogenate
(HBH) for control (Fig. S5E). None of the animals that had been
inoculated with HBH displayed a shortened life span, nor did they
develop any clinical signs of disease - even when kept for
$500 dpi. In contrast, after intranasal prion inoculation all
C57BL/6, 129SvxC57BL/6 and tga20 mice succumbed to scrapie
with an attack rate of 100% (Fig. S5A–C), whereas Prnp
o/o mice
were resistant to intranasal prions (Fig. S5D). After intranasal
inoculation, tga20 mice (n=10, 160628 dpi) displayed a shorter
incubation time (Fig. S5C) than 129SvxC57BL/6 (n=5,
217620 dpi) or C57BL/6 mice (n=8, 266633 dpi; Fig. S5A
and S5B). Further, histological and immunohistochemical analyses
for spongiosis, astrogliosis and PrP deposition pattern confirmed
terminal scrapie (Fig. S5J). A histopathological lesion severity score
Figure 4. Prion transmission through aerosols in complement-deficient and newborn mice. (A) C3C4
2/2 mice and (B) newborn tga20 and
CD1 mice were exposed for 10 min to a 20% aerosolized IBH. Survival curves (right panels) as well as histological and immunohistochemical
characterization of hippocampi indicate that all prion-exposed mice developed scrapie efficiently. Scale bars: 100mm.
doi:10.1371/journal.ppat.1001257.g004
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to prion aerosols (Fig. S5K). However, in the olfactory bulb of
tga20 and 129SvxC57BL/6 mice the score was lower upon
intranasal administration than in the aerosol paradigm (Fig. 2E).
Finally, we tested whether prion transmission via the intranasal
route would be enabled by selective PrP
C expression on neurons.
For that, we inoculated NSE-PrP mice. All intranasally challenged
NSE-PrP mice (n=6, 291686 dpi) succumbed to scrapie. The
incubation time until terminal disease did not differ significantly
from that of 129SvxC57BL/6 control mice (n=5, 217620 dpi;
p=0.0868).
Intranasal prion transmission in the absence of a
functional immune system
Next, we sought to determine which components (if any) of the
immune system are required for neuroinvasion upon intranasal
infection with prions. To address this question, Rag1
2/2 and
cCRag2
2/2 mice were intranasally inoculated with prions
(inoculum RML 6.0, 0.1%, 40ml, equivalent to 4610
5 LD50
scrapie prions). Remarkably, all intranasally prion-inoculated
Rag1
2/2 (n=9, 20366 dpi) (Fig. 5A and H) and cCRag2
2/2
mice (n=16, 243624 dpi) (Fig. 5D and G) succumbed to scrapie,
providing evidence for a LRS-independent mechanism of prion
neuroinvasion upon intranasal administration. Incubation times in
Rag1
2/2 were significantly different to those of intranasally
challenged control mice (C57BL/6; attack rate 100%; n=8,
266633 dpi; p=0.0009) whereas cCRag2
2/2 mice were not
different from those of intranasally challenged control mice
(Balb/c: attack rate 100%, n=6, 209648 dpi, p=0.099) (Fig. 5B
and Fig. 5D).
After intranasal prion administration, PrP
Sc was present in the
CNS of Rag1
2/2 or cCRag2
2/2 mice. WB analysis corroborated
terminal scrapie (Fig. 5G and H). Histopathological lesion severity
scoring revealed a distinct lesion profile characterized by a high
score in the temporal white matter and the thalamus in case of
Rag1
2/2 mice. In case of cCRag2
2/2 mice the cerebellum, the
olfactory bulb and the frontal white matter displayed lower scores
(Fig. 5I and J). In contrast to the CNS spleens of the affected
animals did not contain PK-resistant material in terminally sick
Rag1
2/2 and cCRag2
2/2 mice (Fig. S6E).
For control, Rag1
2/2 as well as cCRag2
2/2 mice were
intranasally inoculated with HBH to test the possibility that
intranasal inoculation itself impacts their life expectancy. None of
the mice inoculated with HBH died spontaneously or developed
scrapie up to $300 dpi (n=4 each; Fig. S6A, C–D). Further,
Balb/c mice and C57BL/6 mice (n=4 each) inoculated
intranasally with HBH (Fig. S5E and S6D) did not develop any
disease for $300 dpi.
As a positive control, Rag1
2/2 mice were i.c. inoculated with
3610
5 LD50 scrapie prions. This led to terminal scrapie disease
after approximately 130 days and an attack rate of 100% (n=3,
13168 dpi) (Fig. 5B and data not shown).
As additional negative controls, Rag1
2/2 and cCRag2
2/2 mice
were i.p. inoculated with prions (100 ml RML 0.1%, 1610
6 LD50).
Although more infectious prions (approximately 2 fold more) were
applied when compared to the intranasal route, i.p. prion
Table 3. PrP
Sc deposition in spleens of mice challenged with a range of aerosolized prion concentrations and exposure times.
Genotype Splenic PrP
Sc in individual mice
#1 #2 #3 #4 #5 #6 #7 #8 #9 #10 #11
Prnp
o/o 2 2 2
Newborn CD1 (20%; 10 min exp.) + + +
CD1 (20%; 1 min exp.) + + + + 2 Nd Nd
CD1 (20%; 5 min exp.) + + 2 2 + Nd Nd
CD1 (20%; 10 min exp.) + + + + + Nd Nd Nd
C57BL/6 (20%; 10 min exp.) + + + +
129SvxC57BL/6 (20%; 10 min exp.) + + + + +
Newborn tga20 (20%; 10 min exp.) + + +
tga20 (0.1%; 10 min exp.) 2 2 2 2
tga20 (2.5%; 10 min exp.) + + + +
tga20 (5%; 10 min exp.) + + + +
tga20 (10%; 10 min exp.) + + + + Nd
tga20 (20%; 1 min exp.) + + + + 2 2
tga20 (20%; 5 min exp.) + + + + + + Nd Nd
tga20 (20%; 10 min exp.) + + + + + + + +
tga20 (20%; 10 min exp.) + + + + + + +
JH
2/2 2 2 2 2
cCRag2
2/2 2 2 2 2 2 2 2 2 2 2 2
C57BL/6 treated with LTbR-Ig 2 2 2
C57BL/6 treated with mu-IgG + + Nd
LTbR
2/2 2 2 2 2
PrP
Sc was assessed on Western blots and histoblots of spleens of Prnp
o/o, newborn CD1, adult CD1, 129SvxC57BL/6, newborn tga20, adult tga20,J H
2/2, cCRag2
2/2,
C57BL/6 mice treated with LTbR-Ig or muIgG and LTbR
2/2 mice. +:P r P
Sc detectable in spleen; 2:P r P
Sc undetectable; Nd: not determined; exp.: exposure time (minutes).
doi:10.1371/journal.ppat.1001257.t003
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2/2 and
cCRag2
2/2 mice (attack rate: 0%, n=4 for each group,
experiment terminated after 400 dpi).
Relevance of the complement system for prion
pathogenesis after intranasal challenge
The complement component C1qa is involved in facilitating the
binding of PrP
Sc to complement receptors on FDCs [56].
Accordingly, C1qa
2/2 mice are resistant to prion infection upon
low-dose peripheral inoculation. CD21
2/2 mice are devoid of the
complement receptor 1, display a normal lymphoid microarchi-
tecture and show a reduction in germinal center size. The
incubation time in CD21
2/2 mice is greatly increased upon
peripheral prion inoculation via the i.p. route [56].
To determine whether the complement system is involved in
prion infection through aerosols, C1qa
2/2 and CD21
2/2 mice were
intranasally inoculated with prions. C1qa
2/2 mice and CD21
2/2
mice succumbed to scrapie with an attack rate of 100% (C1qa
2/2
mice: n=4, 288626 dpi; CD21
2/2 mice: n=10, 235624 dpi)
(Figs. 6A–C), with CD21
2/2 mice succumbing to scrapie slightly
earlier when compared to C1qa
2/2 mice. However, survival times
did not differ significantly from C57BL/6 control mice (n=8,
266633 dpi; C1qa
2/2 mice: p=0.24; CD21
2/2 mice: p=0.05)
(Fig. S5A and S5B). Western blot analysis of one terminally scrapie-
sick C1qa
2/2 mouse revealed one PrP
Sc positive spleen (1/4) (Fig.
S6F). Two terminally scrapie-sick CD21
2/2 mice showed PK
resistance in their spleens (2/10) (Fig. S6G). These results indicate
that the complement components C1qa and CD21 are not essential
for prion propagation upon intranasal application.
CXCR5 deficiency does not shorten prion incubation time
upon intranasal infection
CXCR5 controls the positioning of B-cells in lymphoid follicles,
and the FDCs of CXCR5-deficient mice are in close proximity to
nerve terminals,leadingtoa reduced incubationtime afteri.p.prion
inoculation [39,61]. Here we explored the impact of CXCR5
deficiency onto intranasal prion inoculation. CXCR5
2/2 mice
exhibited attack rates of 100%, and incubation times did not differ
significantly from those of C57BL/6 mice (n=5, 313691 dpi;
p=0.32) (Fig. 6D). 3 out of 5 terminally scrapie-sick CXCR5
2/2
mice revealed PK resistant material in their spleens (3/5), as
detected by Western blot analysis (Fig. S6H).
Prion infection is independent of LTbR and TNFR1
signaling
Pharmacological inhibition of LTbR signaling strongly reduces
peripheral prion replication and reduces or prevents prion
neuroinvasion upon i.p. prion challenge [42,44,53]. To determine
whether inhibition of LTbR signaling would affect prion
transmission through the nasal cavity, we treated C57BL/6 mice
with 100mgL T bR-Ig and for control with 100mg muIgG/mouse/
week pre- and post-prion challenge (27 days, 0 days, +7 days; 14
days). LTbR-Ig-treated mice were then inoculated intranasally
with prions. 100% of the intranasally challenged mice died due to
terminal scrapie (C57BL/6 mice treated with LTbR-Ig: n=8,
4766200 dpi; Fig. 7A). MuIgG treated mice served as controls
and showed an insignificantly shortened incubation time (attack
rate: 100%, n=9, 246629 dpi) (Fig. 7B and C; C57BL/6 LTbR-
Ig treated vs. muIgG treated mice: p=0.014; C57BL/6 untreated
vs. LTbR-Ig treated C57BL/6 mice: p=0.021; C57BL/6
untreated vs. C57BL/6 muIgG treated mice: p=0.22).
We additionally challenged LTbR
2/2, TNFR1
2/2 and LTa
2/2
mice intranasally with RML prions (Fig. 7D–H). Under these
conditions all LTbR
2/2, TNFR1
2/2 and LTa
2/2 mice developed
terminal scrapie (LTbR
2/2 mice: n=6, 291652 dpi; TNFR1
2/2
mice: n=3, 21361 dpi; LTa
2/2 mice: n=6, 251620 dpi)
(Fig. 7D–H). Terminal scrapie was confirmed by immunohisto-
chemistry, histoblot and WB analysis (Fig. 7F and H, data not
Figure 5. Prion transmission by intranasal instillation. (A) Rag1
2/2 mice intranasally inoculated with RML6 0.1%, (B) C57BL/6 mice that have
been intranasally inoculated with 3610
5 LD50 prions. (C) Rag1
2/2 mice i.c. inoculated with 3610
5 LD50,( D) cCRag2
2/2 mice intranasally inoculated with
4610
5 LD50 or (E) Balb/c mice intranasally inoculated with 4610
5 LD50 scrapie prions are shown. Survival curves (A–D) and respective Western blots (F–
G) are indicative of efficient prion neuroinvasion. Brain homogenates were analyzed with (+) and without (2) previous proteinase K (PK) treatment as
indicated. Brain homogenates derived from a terminally scrapie-sick and a healthy C57BL/6 mouse served as positive and negative controls (s: sick; h:
healthy), respectively. Molecular weights (kDa) are indicated on the left side of the blots. (H and I) Histopathological lesion severity score described as
radar blot (astrogliosis, spongiform changeandPrP
Sc deposition) in 5 brain regions of both mouse lines exposed to prion aerosols. Numbers correspond
to the following brain regions: (1) hippocampus, (2) cerebellum, (3) olfactory bulb, (4) frontal white matter, (5) temporal white matter.
doi:10.1371/journal.ppat.1001257.g005
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2/2 and
TNFR1
2/2 mice displayed no PK resistant material (LTbR
2/2
mice: 0/6; TNFR1
2/2 mice: 0/3). In LTa
2/2 mice 1 out of 6
spleens contained PrP
Sc, while splenic PrP
Sc deposits of PK-
resistant material were abundantly found in terminally scrapie-sick
tga20 mice (tga20 mice: 2/10)(Fig. S6I–L).
Figure 6. Intranasal prion transmission in immnunodeficient mice. All mice were intranasally inoculated with 3610
5 LD50 prions. (A) C1qa
2/2
mice intranasally inoculated and (B) CD21
2/2 mice intranasally inoculated are shown. Survival curves illustrate survival after intranasal prion
challenge. Respective Western blots of C1qa
2/2 mice intranasally inoculated (C, left panel) and of CD21
2/2 mice intranasally inoculated (C, right
panel) are shown. Survival curves of CXCR5
2/2 mice intranasally inoculated are shown (D). Respective Western blots of CXCR5
2/2 mice intranasally
inoculated. Brain homogenates were analyzed with (+) and without (2) previous proteinase K (PK) treatment as indicated. Controls and legends are
as in Fig. 5.
doi:10.1371/journal.ppat.1001257.g006
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Although aerial transmission is common for many bacteria and
viruses, it has not been thoroughly investigated for prion aerosols
[11,12,29,30,31,32,33,34,62] and prions are not generally consid-
ered to be airborne pathogens. Yet olfactory nerves have been
discussed as a possible entry site for prions [11], and indeed
contact-mediated prion exposure of nostrils can efficiently infect
various species. We therefore set out to investigate the possible
hazards of prion infection deriving from exposure to prion
aerosols. Our results establish that aerosolized prion-containing
brain homogenates that aerosols are efficacious prion vectors.
Incubation time and attack rate after exposure to prion aerosols
depended primarily on the exposure time, the PrP
C expression
level of recipients and, to a lesser degree, the prion titer of the
materials used to generate prion aerosols in a standardized
inhalation chamber. The paramount role of the exposure time
suggests that the rate of transepithelial ingress of prion through the
airways may be limiting even when prions are offered in relatively
low concentrations. Conversely, the total prion uptake capacity by
the respiratory system was never rate-limiting, because the
incubation time of scrapie decreased progressively with higher
concentrations and longer exposure times, and because we were
unable to establish a response plateau. The latter phenomenon
may be explained by the large alveolar surface potentially
available for prion uptake.
Since it occurred in wt mice of disparate genetic backgrounds
(C57BL/6; CD1; 129SvxC57BL/6), aerosolic infection may
represent a universal phenomenon untied to the genetic
peculiarities of any specific mouse strain (Fig. S7 features a
representative panel of histological features in CD1 mice).
However, in CD1 mice the rapidity of progression to clinical
disease did not correlate with the exposure time at a given
concentration of IBH used for generating prion aerosols,
suggesting the existence of genetic factors modulating the
saturation of aerogenic prion intake.
The passage of infectivity from the peritoneum to the brain
requires a non-hematopoietic conduit that expresses PrP
C [63].
We therefore sought to determine whether such a conduit would
be required for transfer of infectivity from the aerosols to the
brains of recipients. Using NSE-PrP transgenic mice, we found that
neuron-selective expression of PrP
C sufficed to confer susceptibility
of mice to prion infection by aerosols and intranasal application.
Hence PrP
C expression in non-neural tissues is not required for
aerosolic or intranasal neuroinvasion.
Following peripheral exposure, many TSE agents accumulate
and replicate in host lymphoid tissues, including spleen, lymph
nodes, Peyers’ patches, and tonsils [59,64,65,66,67,68,69] in B-cell
and lymphotoxin-dependent process [70,71]. After peripheral
replication in the LRS, prions gain access to the CNS primarily via
peripheral nerves [23]; the innervation of secondary lymphoid
organs and the distance between FDCs and splenic nerve endings
is rate-limiting step for neuroinvasion [38] [39].
In contrast to the above, aerosolic and intranasal exposure led
to prion infection in the absence of B-, T-, NK-cells and mature
FDCs. Although a trend towards a slight delay in incubation time
Figure 7. Intranasal prion transmission is independent of lymphotoxin signaling. C57BL/6 mice treated with LTbR-Ig (A) or control muIgG
(B), and mice lacking various components of the LT/TNF system (D–F, as indicated) were intranasally inoculated with 4610
5 LD50 scrapie prions.
Survival curves (A, B, D, E and G) and respective Western blots (C, F and H) indicate efficient prion infection and neuroinvasion. One animal that
died early after intranasal inoculation (40 dpi) is reported as intercurrent death (i.d.) for reasons other than scrapie. Brain homogenates were analyzed
with (+) and without (2) previous proteinase K (PK) treatment as indicated. Controls and legends used are as in Fig. 1H.
doi:10.1371/journal.ppat.1001257.g007
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2/2 and
C3C4
2/2) and after LTbR-Ig treatment, these differences were
not statistically significant, and all other immunodeficient (JH
2/2,
Rag1
2/2 and cCRag2
2/2) as well as complement-deficient (e.g.
C3C4 and CD21) mice were susceptible to aerosolic and
intranasal prion infection similarly to control mice. We conclude
that transmission into the CNS upon aerosolic prion inoculation
requires neither a functional adaptive immune system nor
microanatomically intact germinal centers with mature FDCs.
Further, the interference with LT signaling, be it by LTbR-Ig
treatment or through ablation of the LTbR, indicates that the
anatomical and functional intactness of lymphoid organs is
dispensable for prion neuroinvasion, brain prion replication, and
clinical scrapie.
Since genetic removal of the main cellular components of the
LRS (e.g. by intercrosses with mice lacking T-, B-cells or NK-cells
in, JH
2/2 or cCRag2
2/2 mice) as well as genetic (LTa
2/2;
LTbR
2/2) or pharmacological (LTbR-Ig) depletion of follicular
dendritic cells - the main cell responsible for prion replication in
secondary lymphoid organs - did not change the course of disease
upon infection with prion aerosols, we conclude that the above
data demonstrate that the LRS is dispensable for prion infection
through the aerogenic route. We therefore propose that airborne
prions follow a pathway of direct prion neuroinvasion along
olfactory neurons which extend to the surface of the olfactory
epithelium. The infectibility of newborn mice supports this
hypothesis, since these mice lacked a fully mature immune system
at the time of prion exposure.
Our results contradict previous studies [12] claiming a role for
the immune system in neuroinvasion upon intranasal prion
infection, but are consistent with recent work [11] showing that
prion neuroinvasion from the tongue and the nasal cavity can
occur in the absence of a prion-infected LRS. Transmission of
CWD to ‘‘cervidized’’ transgenic mice via aerosols and upon
intranasal administration has also been shown [45].
Both LTbR
2/2 and LTa
2/2 mice lack Peyer’s patches and
lymph nodes as well as an intact NALT which may influence prion
replication competence [11,12,29,30,31,32,33,34,63]. Further-
more, these mice display chronic interstitial pneumonia. Consis-
tently with a role for LTbR-signaling in peripheral prion infection,
these mice do not replicate intraperitoneally administered prions.
On the other hand, TNFR1
2/2 mice lack Peyer’s patches, show an
aberrant splenic microarchitecture, an abnormal NALT, but have
intact lymph nodes where prion replication can occur efficiently
[72]. However, prion replication efficacy in spleen is almost
completely abrogated [73] and TNFR1
2/2 mice die due to scrapie
after a prolonged incubation time when peripherally challenged
with prions.
In the present study, all LTa
2/2 mice succumbed to scrapie
upon intranasal infection, whereas some LTa
2/2 mice acquired
prion infection following nasal cavity exposure in a previous study
[11]. The requirement for the LRS in intranasal prion infection
may depend on the particular prion strain being tested and on the
size of the administered inoculum. When present in sufficiently
high titers, prions may be able to directly enter the nervous system
via the nasal mucosa and olfactory nerve terminals (Fig. 8).
However, at limiting doses, aerial prion infection may be
potentiated by an LRS-dependent preamplification step (Fig. 8),
e.g. in the bronchial lymph nodes (BLNs), the nose, the gut-
associated lymphoid tissue (NALT; GALT), or the spleen. In this
study, the particle size generated by the nebulizer ensured that the
entire respiratory tract was flooded by the aerosol so that the
prion-containing aerosolized brain homogenate would reach the
alveolar surface of the lung. There, prions may also colonize
airway-associated lymphoid tissues and gain access to the CNS
(Fig. 8).
Infection through conjunctival or corneal structures was not
required, since newborn mice succumbed to scrapie with an
incidence of 100% despite having closed eyelids. While newborn
tga20, but not CD-1, mice experienced slightly prolonged
incubation times when compared to adult (6–8 week-old) mice
of the same genotype, the anatomical structures of the nasophar-
ynx (e.g. olfactory epithelium and olfactory nerves) are not
similarly developed at postnatal day one when compared to
adulthood, potentially leading to a less efficient prion uptake upon
aerosol exposure (e.g. via olfactory nerves). Although unlikely, it
can not be excluded that infection through conjunctival or corneal
structures might contribute to a more efficient prion infection
upon aerosol exposure. Be as it may, all newborn mice of either
genotypes succumbed to terminal scrapie upon aerosol prion
infection despite their lack of fully developed lymphoid organs,
thereby bolstering our conclusion that the immune system is
dispensable for prion transmission through aerosols.
In summary, our results establish aerosols as a surprisingly
efficient modality of prion transmission. This novel pathway of
prion transmission is not only conceptually relevant for the field
of prion research, but also highlights a hitherto unappreciated
risk factor for laboratory personnel and personnel of the meat
processing industry. In the light of these findings, it may be
appropriate to revise current prion-related biosafety guidelines
and health standards in diagnostic and scientific laboratories
being potentially confronted with prion infected materials. While
we did not investigate whether production of prion aerosols in
nature suffices to cause horizontal prion transmission, the finding
of prions in biological fluids such as saliva, urine and blood
suggests that it may be worth testing this possibility in future
studies.
Material and Methods
Ethics statement
Animals were maintained under specific pathogen-free condi-
tions and experiments were approved and conform to the
guidelines of the Swiss Animal Protection Law, Veterinary office,
Canton Zurich. Mouse experiments were performed under
licenses 40/2002 and 30/2005 according to the regulations of
the Veterinary office of the Canton Zurich and in accordance with
the regulations of the Veterinary office Tu ¨bingen.
Aerosols
Exposure of mice to aerosols was performed in inhalation
chambers containing a nebulizer device (Art.No. 73-1963, Pari
GmbH, Munich, Germany) run with a pressure of 1.5 bar
generating 100% particles below 10 mm with 60% of the particles
below 2.5 mm and 52% below 1.2 mm. Such particle sizes are
considered to be able to reach upper and lower airways [74]. Prion
infected material used throughout this study was RML6 strain
obtained from the brains of diseased CD1 mice in its 6
th passage
(RML6). Mice were exposed to aerosolized prion infected brain
homogenates for one, five or ten minutes.
Intracerebral prion inoculation of mice
tga20 mice serving as indicator mice were inoculated i.c. with
brain tissue homogenate using 30 ml volumes (RML6 0.1%, 3610
5
LD50 scrapie prions). The animals were checked on a daily basis
and were sacrificed when showing defined neurological signs such
as severe gait disorders.
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PLoS Pathogens | www.plospathogens.org 14 January 2011 | Volume 7 | Issue 1 | e1001257Figure 8. Model of the possible pathways of aerogenic prion transmission. (left) Prion aerosols entering the nasal cavity (1) may directly
migrate through the nasal epithelium towards olfactory nerve terminals (2). Subsequently, prions reach olfactory bulb neurons and colonize the
limbic system and other regions of the brain (3). Prions may be taken up by the eyes from where they could be transported via the visual system (e.g.
optic nerves) to the CNS. O: olfactory system; V: visual system. Alternatively (right) prions may be taken up by immune cells residing in (1) the nasal
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Mice were anesthetized with Ketamine/Xylazin hydrochloride
anaesthesia. 10 ml of RML6 (0.1%) were intranasally inoculated in
each nostril and on the nasal epithelium by using a 10 ml pipette.
The mice were held horizontally during inoculation process and
for 1 minute following the inoculation. The whole procedure was
repeated after a break of 20 minutes, reaching a final volume of
40 ml of RML6, 0.1% (4610
5 LD50 scrapie prions).
Intraperitoneal prion application in mice
Mice were anesthetized with Ketamine/Xylazin hydrochloride
anaesthesia. 100 ml of RML6 (0.1%) 1610
6 LD50 scrapie prions
were i.p. inoculated into Rag1
2/2 and cCRag2
2/2 mice.
Western blotting
Tissue homogenates were prepared in sterile 0.32 M sucrose
using a Fast Prep FP120 (Savant, Holbrook, NY, USA) or a
Precellys 24 (Bertin Technologies). For detection of PrP
Sc 15mlo fa
brain homogenate were digested with Proteinase K (30 mg/ml) and
incubated for 30 min at 37uC. For detection of PrP
C no digestion
was performed. Proteins were separated by SDS-PAGE and
transferred to a PVDF (Immobilon-P, Millipore, Bedford, Mass.,
USA) or nitrocellulose membrane (Schleicher & So ¨hne). Prion
proteins were detected by enhanced chemiluminescence (Western
blotting reagent, Santa Cruz Biotechnology, Heidelberg, Germany)
or ECL (from PerbioScience, Lausanne, CH), using mouse
monoclonal anti-PrP antibody POM-1 and horseradish peroxidase
(HRP) conjugated goat anti-mouse IgG1 antibody (Zymed).
Histoblot analysis
Histoblots were performed as described previously [73]. Frozen
brains that were cut into 12 mm-thick slices were mounted on
nitrocellulose membranes. Total PrP, as well as PrP
Sc after
digestion with 50 or 100 mg/ml proteinase K for 4 hrs at 37uC,
were detected with the anti-prion POM1 antibody (1:10000,
NBT/BCIP, Roche Diagnostics).
Histological analysis
Formalin-fixed tissues were treated with concentrated formic
acid for 60 min to inactivate prion infectivity. Paraffin sections
(2mm) and frozen sections (5 or 10mm) of brains were stained with
hematoxylin/eosin. Antibodies GFAP (1:300; DAKO, Carpinteris,
CA) for astrocytes were applied and visualized using standard
methods. Iba-1 (1:1000; Wako Chemicals GmbH, Germany) was
used for highlighting activated microglial cells. Postfixation in
formalin was performed for ,8 hrs and tissues were embedded in
paraffin. After deparaffinisation, for PrP staining sections were
incubated for 6 min in 98% formic acid and washed in distilled
water for 30 min. Sections were heated to 100uC in a steamer in
citrate buffer (pH 6.0) for 3 min, and allowed to cool down to
room temperature. Sections were incubated in Ventana buffer and
stains were performed on a NEXEX immunohistochemistry robot
(Ventana instruments, Switzerland) using an IVIEW DAB
Detection Kit (Ventana). After incubation with protease 1
(Ventana) for 16 min, sections were incubated with anti-PrP
SAF-84 (SPI bio, A03208, 1:200) for 32 min. Sections were
counterstained with hematoxylin.
Lesion profiling
We selected 5 anatomic brain regions from all investigated or at
least 3 mice per experimental group. We evaluated spongiosis on a
scale of 0–4 (not detectable, mild, moderate, severe and status
spongiosus). Gliosis and PrP immunological reactivity was scored
on a 0–3 scale (not detectable, mild, moderate, severe). A sum of
the three scores resulted in the value obtained for the lesion profile
for the individual animal. The ‘radar plots’ depict the scores for
spongiform changes, gliosis and PrP deposition. Numbers
correspond to the following brain regions: (1) hippocampus, (2)
cerebellum, (3) olfactory bulb, (4) frontal white matter, (5)
temporal white matter. Investigators blinded to animal identifica-
tion performed histological analyses.
Misfolded Protein Assay (MPA)
Misfolded Protein Assay (MPA) was performed as described
previously [75]. The assay, which was performed on a 96-well
plate is divided into two parts: the PSR1 Capture and an ELISA.
For the PSR1 Capture the set up of each reaction was as following:
3mL of PSR1 beads (buffer removed) and 100mlo f1 6 TBSTT
were spiked with brain homogenate, incubated at 37uC for 1hr
with shaking at 750rpm, the beads were washed on the plate
washer (ELX405 Biotek) 8 times with residual 50 ml/well TBST.
Then 75ml/well of denaturing buffer was added. This was
incubated at RT for 10min with shaking at 750rpm. Subsequently
30ml/well of neutralizing buffer were added. An additional
incubation at RT for 5min with shaking at 750rpm followed.
The beads were pulled down with a magnet. The ELISA was
performed as follows: 150mL/well of the sample was transferred to
an ELISA plate which was coated with POM19. An incubation
step at 37uC for 1hr with shaking at 300rpm followed. That was
washed 6 times with wash buffer. POM2-AP conjugate had to be
diluted to 0.01mg/mL in conjugate diluent. 150mL/well of diluted
conjugate was added. Incubation at 37uC for 1hr without shaking
followed. Washing 6 times with wash buffer was followed by
preparation of enhanced substrate by adding 910mL of enhancer
to 10mL of substrate (Lumiphos plus, Lumigen). 150mL/well of
enhanced substrate was added. Incubation at 37uC for 30min was
followed by reading by luminometer (Luminoskan Ascent) at
default PMT, filter scale=1.
Real-time RT-PCR for quantification of the transgene
copy number in Prnp
o/o/NSE-PrP mice
Real-time PCR was performed on purified genomic DNA from
mouse tails on a 7900 HT Fast Real-Time PCR System (AB). Data
were generated and analyzed using SDS 2.3 and RQ manager 1.2
software. The following primers were used: Forward primer
annealing in mouse Prnp gene intron 1: 59 - GGT TTG ATG ATT
TGC ATA TTA G - 39. Reverse primer annealing in mouse Prnp
gene exon 2: 59 - GGA AGG CAG AAT GCT TCA GC - 39. The
PCR product is approximately 200 bps in length. For control, the
mouse Lymphotoxin alpha gene was analyzed. The following
primers were used: Forward primer annealing to the Exon 1 of the
mouse Lymphotoxin alpha gene: 59 - CCT GGT GAC CCT
GTT GTT GG - 39. Reverse primer annealing to the mouse
Lymphotoxin alpha gene Intron 1: 59 - GTG GGC AGA AGC
ACA GCC - 39. The PCR product is approximately 160 bps in
cavity, the lung, or (2) the gastrointestinal tract, from where they may be transferred to lymphoreticular system (LRS) components such as bronchial
lymph nodes (BALT), nasal associated lymphoid tissue (NALT), gastrointestinal lymphoid tissue (GALT), mesenteric lymph nodes, or spleen for further
amplification. Subsequently, prions traffic towards peripheral nerve terminals (PNS), from where they invade the central nervous system (CNS). SC:
spinal cord. Arrows indicate possible migration directions of prions once they have invaded the spinal cord.
doi:10.1371/journal.ppat.1001257.g008
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Prnp allele in Prnp
o/o/NSE-PrP mice.
Statistical evaluation
Results are expressed as the mean+standard error of the mean
(SEM) or standard deviation (SD) as indicated. Statistical
significance between experimental groups was assessed using an
unpaired two-sample Student’s t-Test (Excel) and two-sample
Welch t-Test for distributions with unequal variance (R). For
survival analyses, Kaplan-Meier-survival curves were generated
using SPSS or R software, statistical significance was assessed by
performing log rank tests (R). Linear regression fits and analyses of
variance (ANOVA) were conducted in R (www.r-project.org).
Supporting Information
Figure S1 Analysis of variance (ANOVA) for various genotypes
regarding incubation times. Dot plot of survival times for tga20,
CD1, C57BL/6 and 129SvxC57BL/6 mice after 10 min exposure
to IBH. The difference between genotypes is significant (p,0.001).
Found at: doi:10.1371/journal.ppat.1001257.s001 (0.14 MB TIF)
Figure S2 Prion transmission through aerosols or upon
intranasal challenge cannot be directly followed by Western blot
and PMA. (A–D) Western blot analysis for PrP
Sc of the
compartments olfactory epithelium (OE), olfactory bulb (OB),
one brain hemisphere or the cerebellum at 60 days post aerosolic
infection in different mouse strains (C57BL/6, CXCR5
2/2,
CD21
2/2, Prnp
o/o, CD1, LTa
2/2, NSE-PrP, TNFR1
2/2 mice).
(+) and without (2) previous proteinase K (PK) treatment as
indicated. Molecular weights (kDa) are indicated on the right side
of the blots. kDa: Kilo Dalton. b-Actin served as a loading control.
(E) Analysis of brain tissue homogenates from intranasally
inoculated mice by the ‘‘misfolded protein assay’’ (MPA) reveals
positive signals as indicators of Prp
Sc deposition in the control
specimen (red) and negative signal in most cases investigated (blue,
below wt level). The brain of a wt mouse was used as control
(black). Y-axis: RLU: Relative (Chemi) Luminescence Units, X-
axis: mouse number, blue column represents a 1:10 dilution of a
10% brain homogenate. Data for uninfected brain controls are not
shown here, but did not display a positive signal. (F) Analysis of
olfactory bulb tissue homogenates from intranasally inoculated
mice by the ‘‘misfolded protein assay’’ (MPA) reveals positive
signals as indicators of Prp
Sc deposition in the control specimen
(red) and in diseased mice (positive signals). Negative signals in
most other cases investigated (blue bars under wt control level).
The brain of a wt mouse was used as control (black). Y-axis: RLU:
Relative (Chemi) Luminescence Units, X-axis: mouse number,
blue column represents a 1:10 dilution of a 10% brain
homogenate. Data for uninfected brain controls are not shown
here, but did not display a positive signal.
Found at: doi:10.1371/journal.ppat.1001257.s002 (0.68 MB TIF)
Figure S3 Detailed quantitative analysis of PrP
C expression in
the olfactory epithelium and the CNS. (A) Quantification of
PrP
C expression levels by Western blotting in NSE-PrP, wt and
tga20 mice. In the olfactory epithelium tga20 mice $3.5 fold
higher PrP
C expression compared to wt mice and approximately
11 fold higher PrP
C expression compared to NSE-PrP mice. (B)I n
the olfactory bulb of tga20 mice $1.5 fold higher PrP
C expression
compared to wt mice and more than 3.5 fold higher PrP
C
expression compared to NSE-PrP mice. (C) In brain hemispheres
of tga20 mice more than 2.5 fold higher PrP
C expression compared
to wt mice, and more than 1.5 fold higher PrP
C expression
compared to NSE-PrP mice. Molecular weights (kDa) are indicated
on the right side of the blots. kDa: Kilo Dalton. b-Actin served as a
loading control.
Found at: doi:10.1371/journal.ppat.1001257.s003 (1.48 MB TIF)
Figure S4 Splenic involvement after prion transmission through
aerosols and involvement of the spleen. (A) tga20 mice, (B)J H
2/2
mice, (C)L T bR
2/2 mice and (D) cCRag2
2/2 mice in part show
splenic deposits of PK resistant material, evaluated by Western blot
analysis. (E) Histoblot analysis of spleens of C57BL/6, of Prnp
o/o
and of Rag1
2/2 mice. C57BL/6 mice reveal PK resistant deposits
while Prnp
o/o and Rag1
2/2 mice lack such deposits. (F) Western blot
analysis of a representative tga20 spleen, mesenteric lymph node
(mln) and bronchial lymph node (bln) lacking PK-resistant material.
(+)a n d( 2) with or without PK treatment. POM1 was used as
primary antibody.
Found at: doi:10.1371/journal.ppat.1001257.s004 (2.81 MB TIF)
Figure S5 Prion transmission via the intranasal route. Survival
curves of (A) C57BL/6, (B) 129SvxC57BL/6 (C) tga20 and (D)
Prnp
o/o mice that have been intranasally inoculated with RML6
0.1%. (E) Survival curve of C57BL/6 mice that have been
intranasally inoculated with HBH. Western blots of brains of (F)
C57BL/6 mice and of (G) tga20 mice that have been intranasally
inoculated with 4610
5 LD50 scrapie prions. Brain homogenates
were analyzed with (+) and without (2) previous proteinase K (PK)
treatment as indicated. Homogenate derived from a terminally
scrapie-sick mouse served as positive control (s: sick), and healthy
C57BL/6 mouse brain homogenate as negative control (h:
healthy), respectively. Molecular weights (kDa) are indicated on
the left side of the blots. (H) Survival curves of NSE-PrP mice
intranasally inoculated with prions are shown (left panel).
Respective Western blots of NSE-PrP mice intranasally inoculated
with prions are shown (right panel). Brain homogenates were
analyzed with (+) and without (2) previous proteinase K (PK)
treatment as indicated. Homogenate derived from a terminally
scrapie-sick mouse served as positive control (s: sick), and healthy
C57BL/6 mouse tissue as negative control (h: healthy), respec-
tively and i.d. indicates intercurrent death of animal. Molecular
weights (kDa) are indicated on the left side of the blots. (I)
Histoblot analysis of prion infected mouse brains. Left panel:
shows healthy brain of a Prnp
o/o mouse as negative control, other
panels demonstrate Prp
Sc deposits in brains of tga20 mice. Scale
bars are indicated. (J) Histological and immunohistochemical
characterization of scrapie affected mouse brains. Brain sections of
Prnp
o/o, tga20, 129SvxC57BL/6 and C57BL/6 mice as evaluated
by HE (for spongiosis, gliosis, neuronal cell loss), SAF84 (for PrP
Sc
deposits), GFAP (for astrogliosis) and Iba-1 (for microglial
activation). Scale bars: 100mm. (K) Histopathological lesion
severity score of 5 brain regions described as radar blot
(astrogliosis, spongiform change and PrP
Sc deposition) of intrana-
sally prion inoculated tga20, C57BL/6 and 129SvxC57BL/6 mice.
Found at: doi:10.1371/journal.ppat.1001257.s005 (1.04 MB TIF)
Figure S6 Prion transmission via the intranasal route, controls
and involvement of the spleen. (A) Rag1
2/2 mice intranasally
inoculated with HBH (40 ml) or (B) C57BL/6 intranasally
inoculated with 4610
5 LD50 scrapie prions. (C) cCRag2
2/2 mice
intranasally inoculated with HBH (40 ml) or (D) Balb/c mice
intranasally inoculated with HBH are shown. Kaplan-Meier
curves describe the percentage of survival after particular time
points post intranasal prion inoculation (y-axis represents percent-
age of living animals; x-axis demonstrates survival time in days).
Respective Western blots of (E) spleens and bln of terminal Rag1
2/2
mice, (F) of spleens of terminal C1qa
2/2 mice, (G) spleens of
terminal CD21
2/2 mice, (H) spleensof terminal CXCR5
2/2 mice,
(I) spleens of terminal LTbR
2/2 mice, (J) spleens of terminal
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2/2 mice, (K) spleens of terminal LTa
2/2 and LTbR
2/2
mice and (L) spleens of terminal tga20 mice.
Found at: doi:10.1371/journal.ppat.1001257.s006 (1.41 MB TIF)
Figure S7 Histological, immunohistochemical and immunoblot
confirmation of prion disease upon aerosol infection. (A, B)
Histological and immunohistochemical characterization of scrapie
affected CD1 mouse brains. (A) Representative olfactory bulbs
(HE and Neurofilament stains) are shown. scale bars indicated (B)
The cerebellum (upper row), the midbrain (second row from top),
the frontal cortex (third row from top) and the olfactory bulb
(lower row) display spongiosis, astrogliosis, microglial activation
and Prp
Sc deposits upon prion infection via aerosols (HE, GFAP,
Iba-1 and SAF-84 staining). Scale bars: 50 cm.
Found at: doi:10.1371/journal.ppat.1001257.s007 (8.63 MB TIF)
Table S1 Survival times of mouse strains exposed to
prion aerosols for various periods. (A) Analysis of variance
for plates in Fig. 1F–G and Fig. S1. The time of exposure to
aerosolized infectious brain homogenates, but not their concen-
tration, significantly correlated with survival time. (B) Linear
regression fits for survival time against exposure time in tga20
(Fig. 1G) and CD1 (Fig. S1) mice. Incubation times correlated
negatively with PrP expression level. (C) Pair wise tests for differing
mean survival time for tga20, CD1, C57BL/6 and 129SvxC57BL/
6 mice after 10 minutes exposure to prion aerosols (Fig. S1),
identifying Prnp gene copy number as the strongest independent
variable. P,0.001: ***, P,0.01: **, P,0.05: *, P,0.1.
Found at: doi:10.1371/journal.ppat.1001257.s008 (0.06 MB
DOC)
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